Drug Approval | July 13, 2025
Moderna receives USFDA approval for Covid-19 vaccine ‘Spikevax’
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The company’s largest center for medical device applications, serving the entire Asian market
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Subscribe To Our Newsletter & Stay Updated
